Impending Net Drug Price Transparency Regulatio...

By Rene Pretorius

June 27, 2025

A new CMS rule to force drug price transparency is poised to reshape the pharmaceutical and healthcare landscape. With regulat...
Transparency in Industry Partnerships: Building Trust
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Pr...
Canada Launches Consultation for Essential Prescription Drugs List
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
NICE Approves Transformative Multiple Myeloma Treatment
Telemedicine Growth Strategies: Insights from the WHO European Region
Future-Proofing Hospitals: Singapore’s Blueprint for Smarter Healthcare
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics
What are the Plans and Implications for Keytruda´s Biosimilar